주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-04-19 11:13 (Fri)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
214 )
기사목록 보기 형태
제목형
요약형
포토형
‘Yuhan’s Lazertinib promising as 1st-line therapy for NSCLC’
Jeong Sae-im
2019.06.18 14:31
Korea can benchmark Philadelphia’s rise as ‘Cellicon Valley’: experts
Jeong Sae-im
2019.06.18 11:18
Korean biosimilars take on original drugs in Europe
Jeong Sae-im
2019.06.17 15:06
294 shareholders file suit against Kolon TissueGene for damage compensation
Jeong Sae-im
2019.06.14 10:47
‘Many drugs won Chinese approval without review suspension’
Jeong Sae-im
2019.06.13 11:21
Daewoong’s botulinum toxin hits a snag in European approval
Jeong Sae-im
2019.06.12 15:26
‘Medytox got review suspension in China only once’
Jeong Sae-im
2019.06.11 10:42
CJ HealthCare to invest ₩100 billion in new IV fluid factory
Jeong Sae-im
2019.06.10 15:28
Medytox’ botulinum toxin may face approval delay in China
Jeong Sae-im
2019.06.10 11:44
Kolon TissueGene CEO resigns
Jeong Sae-im
2019.06.07 15:29
Pharma industry urges deregulation to develop new drug using AI
Jeong Sae-im
2019.06.05 11:48
FDA OKs phase-1 trial for Yuhan’s investigational lung cancer drug
Jeong Sae-im
2019.06.04 13:01
처음
이전
이전
이전
11
12
13
14
15
16
17
18
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기